BDBM192472 US9187466, 122::US9687476, 122

SMILES OC(Cn1c(nn(Cc2cccc(c2)-c2ccccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F

InChI Key InChIKey=BSYIUTMEBAJKRA-UHFFFAOYSA-N

Data  4 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 192472   

TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192472(US9187466, 122 | US9687476, 122)
Affinity DataIC50:  570nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192472(US9187466, 122 | US9687476, 122)
Affinity DataIC50:  27nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192472(US9187466, 122 | US9687476, 122)
Affinity DataIC50:  570nMT: 2°CAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM192472(US9187466, 122 | US9687476, 122)
Affinity DataIC50:  27nMAssay Description:On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates an...More data for this Ligand-Target Pair
In DepthDetails US Patent